Use of dexmedetomidine in the pediatric intensive care unit

Pharmacotherapy

Volumn 28, Issue 1, 2008, Pages 51-57

  Buck, Marcia L ^a,b   Willson, Douglas F ^a  

^a UNIVERSITY OF VIRGINIA CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Children; Dexmedetomidine; Infant; Mechanical ventilation; Pediatric intensive care; Sedation

Indexed keywords

DEXMEDETOMIDINE; FENTANYL; MIDAZOLAM; MORPHINE; OPIATE;

ADOLESCENT; ARTICLE; ARTIFICIAL VENTILATION; BLOOD PRESSURE; CHILD; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CRITICALLY ILL PATIENT; DOWN SYNDROME; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; DRUG SAFETY; DRUG WITHDRAWAL; ENDOCARDITIS; EXTUBATION; FEMALE; HEART RATE; HEART SURGERY; HUMAN; HYPOTENSION; INFANT; INTENSIVE CARE UNIT; MALE; NEUROLOGIC DISEASE; NEWBORN INTENSIVE CARE; PAIN; PATIENT SELECTION; PROSPECTIVE STUDY; RECOMMENDED DRUG DOSE; RESPIRATORY FAILURE; SCOLIOSIS; SEDATION; SURGICAL PATIENT; TREATMENT OUTCOME;

CHILD; DEXMEDETOMIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; HUMANS; HYPNOTICS AND SEDATIVES; HYPOTENSION; INFANT; INFUSIONS, INTRAVENOUS; INTENSIVE CARE; INTENSIVE CARE UNITS, PEDIATRIC; MIDAZOLAM; PROSPECTIVE STUDIES; RECEPTORS, ADRENERGIC, ALPHA-2; TIME FACTORS; TREATMENT OUTCOME;

EID: 38049037886     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.28.1.51     Document Type: Article

References (24)

1. Gerlach AT, Dasta JF. Dexmedetomidine: an updated review. Ann Pharmacother 2007;41:245-54.
2. MacLaren R, Forrest LK, Kiser TH. Adjunctive dexmedetomidine therapy in the intensive care unit: a retrospective assessment of impact on sedative and analgesic requirements, levels of sedation and analgesia, and ventilatory and hemodynamic parameters. Pharmacotherapy 2007;27:351-9.
3. Dasta JF, Kane-Gill SL, Durtschi AJ. Comparing dexmedetomidine prescribing patterns and safety in the naturalistic setting versus published data. Ann Pharmacother 2004;38:1130-5.
4. Tobias JD, Berkenbosch JW. Initial experience with dexmedetomidine in paediatric-aged patients. Paediatr Anaesth 2002;12:171-5.
5. Tobias JD, Berkenbosch JW, Russo P. Additional experience with dexmedetomidine in pediatric patients. Southern Med J 2003;96:871-5.
6. Tobias JD, Berkenbosch JW. Sedation during mechanical ventilation in infants and children: dexmedetomidine versus midazolam. South Med J 2004;97:451-5.
7. Serlin S. Dexmedetomidine in pediatrics: controlled studies needed [letter]. Anesth Analg 2004;98:1814.
8. Berkenbosch JW, Wankum PC, Tobias JD. Prospective evaluation of dexmedetomidine for noninvasive procedural sedation in children. Pediatr Crit Care Med 2005;6:435-9.
9. Finkel JC, Johnson YJ, Quezado ZMN. The use of dexmedetomidine to facilitate acute discontinuation of opioids after cardiac transplantation in children. Crit Care Med 2005;33:2110-2.
10. Koroglu A, Demirbilek S, Teksan H, Sagir O, But AK, Ersoy MO. Sedative, haemodynamic and respiratory effects of dexmedetomidine in children undergoing magnetic resonance imaging examination: preliminary results. Br J Anaesth 2005;94:821-4.
11. Chrysostomou C, Zeballos T. Use of dexmedetomidine in a pediatric heart transplant patient. Pediatr Cardiol 2005;26: 651-4.
12. Chrysostomou C, Di Filippo S, Manrique A, et al. Use of dexmedetomidine in children after cardiac and thoracic surgery. Pediatr Crit Care Med 2006;7:126-31.
13. Enomoto Y, Kudo T, Saito T, et al. Prolonged use of dexmedetomidine in an infant with respiratory failure following living donor liver transplantation. Paediatr Anaesth 2006;16:1285-8.
14. Walker J, MacCallum M, Fischer C, Kopcha R, Saylors R, McCall J. Sedation using dexmedetomidine in pediatric burn patients. J Burn Care Res 2006;27:206-10.
15. Luscri N, Tobias JD. Monitored anesthesia care with a combination of ketamine and dexmedetomidine during magnetic resonance imaging in three children with trisomy 21 and obstructive sleep apnea. Paediatr Anaesth 2006;16:782-6.
16. Munro HM, Tirotta CF, Felix DE, et al. Initial experience with dexmedetomidine for diagnostic and interventional cardiac catheterization in children. Pediatr Anesth 2007;17:109-12.
17. Tobias JD. Dexmedetomidine: applications in pediatric critical care and pediatric anesthesiology. Pediatr Crit Care Med 2007;8:115-31.
18. Gerlach AT, Dasta J, Armen S, et al. Titration protocol reduces hypotension during dexmedetomidine infusion in critically ill surgical patients [abstract]. Crit Care Med 2006;34(suppl): A148.
19. Petroz GC, Sikich N, James M, et al. A phase 1, two-center study of the pharmacokinetics and pharmacodynamics of dexmedetomidine in children. Anesthesiology 2006;105: 1098-110.
20. Merkel SI, Voepel-Lewis T, Shayevitz JR, Malviya S. The FLACC: a behavioral scale for scoring postoperative pain in young children. Pediatr Nurs 1997;23:293-7.
21. Shehabi Y, Ruettimann U, Adamson H, Innes R, Ickeringill M. Dexmedetomidine infusion for more than 24 hours in critically ill patients: sedative and cardiovascular effects. Intensive Care Med 2004;30:2188-96.
22. Napoli KL, Ingall CG, Martin GR. Safety and efficacy of chloral hydrate sedation in children undergoing echocardiography. J Pediatr 1996;129:287-91.
23. Gakhal B, Scott CS, MacNab AJ. Comparison of morphine requirements for sedation in Down's syndrome and non-Down's patients following paediatric cardiac surgery. Paediatr Anaesth 1998;8:229-33.
24. Munoz R, Berry D. Dexmedetomidine: promising drug for pediatric sedation? Pediatr Crit Care Med 2005;6:493-4.